Cipher Pharmaceuticals Inc.
CPHRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 57.7% | 2.4% | -5.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 72.2% | 80.8% | 80.7% | 83.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 35.6% | 54.5% | 57.8% | 62.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 34.6% | 96.3% | 128.8% | 35.4% |
| EPS Diluted | 0.46 | 0.8 | 0.99 | 0.29 |
| % Growth | -42.5% | -19.2% | 241.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |